BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential

Loading news article.

BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential | WAPE

BridgeBio Pharma Says To Expand State Medicaid Access To Marketed Medicine Via Generous Model; To Offer Attruby Via Medicare Part D Without Future Pricing Mandates; Agreement Does Not Impact ForgingBridges Copay Assistance Program; Does Not Expect Future Pricing Mandates; Terms Remain Confidential

Article summary

Related companies

Comments —